3 h. ago China’s healthcare segment eyes record fundraising amid global investor surge

China’s healthcare segment eyes record fundraising amid global investor surge  South China Morning Post

Economics

5 d. ago Venture firm Lanchi doubles down on Chinese AI, robotics start

Chinese venture capital firm Lanchi Ventures is doubling down on investing in China’s artificial intelligence and robotics start-ups while raising a new fund amid increased global investor appetite for the country’s early-stage tech firms, its executives said. Lanchi Ventures, formerly known as BlueRun Ventures China, would continue to be “all in” on AI and robotics, focusing on AI applications, multimodal AI models and firms targeting overseas markets, managing partner Jui Tan said in an...

Politics

1 week ago How Asian consumers are driving a revolution in healthier food choices

Asia’s rising middle classes are not just fuelling economic growth – they’re reshaping consumption itself. Nowhere is this transformation more visible than in the region’s embrace of healthier eating. From Hong Kong to Jakarta, a new generation of consumers is driving a quiet revolution in food choices. But is this a more lasting realignment of preferences or merely a pandemic-fuelled detour? Market research suggests consumer attention on health will grow. China’s healthcare-related consumer...

Politics

2 w. ago South Korean investors ride China’s tech wave with big stock buys in 2025

Since buying stock in China’s robotics firms over the last year – companies emerging as global industry leaders – David Choi, a South Korean investor in his early 30s, has been riding a wave of strong gains. He is not alone. Many South Korean investors have begun exploring positions in Chinese equities, particularly in rapidly growing arenas like tech. “Those who follow what’s going on in the tech industry already see how fast China has been developing on many fronts,” said Choi, who works in...

Economics

2 w. ago China’s rise in biotech could lower healthcare costs, investor says

China’s rise in biotech innovation offers the world a potentially cheaper alternative to costly healthcare products from Western suppliers, but geopolitical tensions remain a major challenge for the country’s globalisation efforts, according to a local investor in the sector. “We can lower the cost of healthcare and benefit more people through technological innovation and efficiency improvement,” Da Liu, managing director of CR-CP Life Science Fund, said in an interview with the Post earlier...

Economics

3 w. ago Hong Kong can’t afford to outsource its healthcare to mainland China

In recent years, Hongkongers have developed a new habit: going north for their medical check-ups. A 2024 survey found nearly one in three residents had sought medical care in mainland China. The reasons are as predictable as they are troubling: shorter queues, cheaper drugs and upfront prices. If this trend sounds like a temporary release valve for a stressed system, think again. What we’re seeing isn’t a convenient side option; it’s an unofficial outsourcing of healthcare. Left unchecked, it...

Politics